Beijing Wehand-Bio Pharmaceutical Co.,Ltd.


Beijing Wehand-Bio Pharmaceutical Co.,Ltd.established in 2010, is a bio-pharmaceutical company specializing in the R&D, industrialization, and commercialization of high-technology-barrier original innovative drugs. Driven by clinical value, the company focuses on major therapeutic areas such as metabolic diseases, malignant tumors, and immune system disorders. It is committed to developing market-exclusive natural medicines with the potential for treating comorbid metabolic disorders, and innovative drug delivery systems. The company has been recognized as a national high-tech "Little Giant" enterprise, a "National High-tech Enterprise", a "National Intellectual Property Advantage Enterprise", a "Zhongguancun Major Frontier Original High-end and Precision Enterprise", a "Specialized, Refined, Distinctive, and Innovative Enterprise", and a "Beijing Municipal Enterprise Technology Center".

Mulberry Twig Alkaloids Tablets

Sangzhi Alkaloid Tablets(Sangbo’en)is the first domestically developed Natural Medicine in China for the treatment of diabetes, and the first plant-derived Natural Medicine globally demonstrating efficacy in glucose reduction. It is also the world’s first Natural Medicine validated through high-standard randomized, double-blind, multicenter, large-scale head-to-head clinical trials comparing directly with chemical-based drugs, adopting glycosylated hemoglobin (“HbA1c”), the international gold-standard efficacy endpoint for diabetes treatments, as the primary evaluation indicator, thereby obtaining high-level evidence-based clinical support.

The 3rd Sino- German Cross-Border Pharmaceutical Health Industry Cooperation & Exchange Conference